R5 Final QA

This page is part of the FHIR Specification (v5.0.0-draft-final: Final QA Preview for R5 - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Example MedicinalProductDefinition/example (Narrative)

Biomedical Research and Regulation Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicinalProductDefinition.

Generated Narrative

Id: example

Identifier: {mpid}

Classification: ATC: B01AF02

Attached Document: (SmPC)

Master File: (Pharmacovigilence Master File)

Product Name: Equilidem 2.5 mg film-coated tablets

Name Part

part:Equilidem

type: Invented

Name Part

part:2.5 mg

type: Strength

Name Part

part:film-coated tablets

type: Form

Country & Languages

- Country Jurisdiction Language
* EU EU EN

Manufacturing & Business Operations

- Type EffectiveDate Authorization
* Batch Release 2013-03-15 --> (ongoing) 1324TZ

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.